ðŸ‡ðŸ‡° English, 6 November 2026, data center
Hong Kong can help 'bend the curve' on rising drug costs
Financial Secretary Paul Chan says Hong Kong can play a key role in reversing the rising cost of bringing new medicines to patients
Chan highlighted the power of the city’s capital markets, noting Hong Kong has become the world’s second-largest fundraising centre for biotechnology since listing reforms for pre-revenue biotech firms in 2018.
The establishment of the Hong Kong Centre for Medical Products Regulation and efforts in Hetao to make it easier for data and biosamples to move across the boundary are also mentioned.
Chan said Hong Kong’s role is increasingly clear: to bring models, patients, markets and capital together, and reduce the time and cost of bringing new treatments to market.